Safety and Immunogenicity of Neonatal Pneumococcal Conjugate Vaccination in Papua New Guinean Children: A Randomised Controlled Trial

BACKGROUND: Approximately 826,000 children, mostly young infants, die annually from invasive pneumococcal disease. A 6-10-14-week schedule of pneumococcal conjugate vaccine (PCV) is efficacious but neonatal PCV may provide earlier protection and better coverage. We conducted an open randomized contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Pomat, William S., van den Biggelaar, Anita H. J., Phuanukoonnon, Suparat, Francis, Jacinta, Jacoby, Peter, Siba, Peter M., Alpers, Michael P., Reeder, John C., Holt, Patrick G., Richmond, Peter C., Lehmann, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579820/
https://www.ncbi.nlm.nih.gov/pubmed/23451070
http://dx.doi.org/10.1371/journal.pone.0056698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579820/
https://www.ncbi.nlm.nih.gov/pubmed/23451070
http://dx.doi.org/10.1371/journal.pone.0056698

Ejemplares similares